Affordable Access

deepdyve-link
Publisher Website

Diagnosis and management of typical, newly diagnosed primary immune thrombocytopenia (ITP) of childhood.

Authors
  • Friedman, Jeremy N1
  • Beck, Carolyn E1
  • 1 Canadian Paediatric Society, Acute Care Committee, Ottawa, Ontario.
Type
Published Article
Journal
Paediatrics & child health
Publication Date
Feb 01, 2019
Volume
24
Issue
1
Pages
54–55
Identifiers
DOI: 10.1093/pch/pxy197
PMID: 30833822
Source
Medline
Keywords
Language
French
License
Unknown

Abstract

This practice point applies to children aged 90 days through 17 years who have typical, newly diagnosed primary immune thrombocytopenia (ITP). Current recommendations on management and information from recent studies are summarized with the goal of decreasing variable practice among providers and improving patient-centred care. Options for initially managing young patients with ITP who experience bruising, petechiae, or occasional mild epistaxis not interfering with daily living include observation without pharmacotherapy as a first-line option. When active therapy is pursued, choices include the use of corticosteroids and intravenous immunoglobulin. Children with moderate or severe bleeding continue to require hospitalization and treatment. Shared decision-making can enhance patient-centred care and ensure that the families have a full understanding of the management options available.

Report this publication

Statistics

Seen <100 times